News & Updates

Show Multimedia Only

CGM improves glycaemic excursion detection in T2D patients on haemodialysis

21 Nov 2025

Continuous glucose monitoring (CGM) among individuals with type 2 diabetes (T2D) and end-stage kidney disease (ESKD) on haemodialysis helps enhance the detection of hyperglycaemic and hypoglycaemic events, particularly nocturnal and prolonged episodes, suggests a study.

CGM improves glycaemic excursion detection in T2D patients on haemodialysis

21 Nov 2025

For Asians with PCOS, ovarian reserve remains high even at advanced maternal age

19 Nov 2025 by

Asian women with polycystic ovary syndrome (PCOS) may have longer reproductive potential, with a high ovarian reserve that is maintained through older age and translates to increased success with assisted reproductive technology (ART) treatments, according to a retrospective study.

For Asians with PCOS, ovarian reserve remains high even at advanced maternal age

19 Nov 2025

Closed-loop insulin system improves T1D management in pregnancy

17 Nov 2025 by

For pregnant women with type 1 diabetes (T1D), the use of a closed-loop insulin system helps increase time spent in target glucose range, according to the open-label CIRCUIT trial.

Closed-loop insulin system improves T1D management in pregnancy

17 Nov 2025

Breastfeeding may help prevent early puberty

12 Nov 2025

Children who were breastfed during the first 4–6 months of life are less likely to have central precocious puberty (CPP), with the protective association being partially mediated by prepubertal adiposity, according to a retrospective study.

Breastfeeding may help prevent early puberty

12 Nov 2025

High plasma triglycerides protect patients with PD against cognitive impairment

08 Nov 2025

In patients with Parkinson’s disease (PD), the high risk of mild cognitive impairment (MCI) at the time of diagnosis correlates with low levels of plasma triglycerides (P-TG) and an interaction between change in BMI and P-TG prior to diagnosis, reports a study.

High plasma triglycerides protect patients with PD against cognitive impairment

08 Nov 2025

Liraglutide promotes weight loss after suboptimal response to bariatric surgery

07 Nov 2025 by

For patients who are struggling to lose weight after metabolic bariatric surgery, treatment with liraglutide boosts weight-loss outcomes and helps avoid conversion surgery, as shown in a randomized clinical trial.

Liraglutide promotes weight loss after suboptimal response to bariatric surgery

07 Nov 2025

High BMI tied to ulnar nerve entrapment development in nondiabetic individuals

06 Nov 2025 by

A longitudinal study from Sweden shows an association between high BMI and the development of ulnar nerve entrapment (UNE) in a middle-aged cohort of individuals without diabetes from northern Europe, with over 25 years of follow-up.

High BMI tied to ulnar nerve entrapment development in nondiabetic individuals

06 Nov 2025

SGLT-2i lowers autoimmune rheumatic disease risk in T2D

04 Nov 2025 by

The use of sodium-glucose cotransporter-2 (SGLT-2) inhibitors, compared with sulfonylureas, results in a reduced risk of autoimmune rheumatic disease among adults with type 2 diabetes (T2D), reports a recent study.

SGLT-2i lowers autoimmune rheumatic disease risk in T2D

04 Nov 2025

Semaglutide safe for dialysis patients in pooled analysis

04 Nov 2025 by

Treatment with the GLP-1 receptor agonist semaglutide appears safe for patients initiating dialysis, as demonstrated in a pooled analysis presented at EASD 2025.

Semaglutide safe for dialysis patients in pooled analysis

04 Nov 2025

Empagliflozin 25 mg confers greater kidney protection than SGLT2i 10 mg in T2D

03 Nov 2025 by

In patients with type 2 diabetes (T2D), empagliflozin 25 mg daily offers greater kidney protection than its 10 mg daily dose or dapagliflozin 10 mg daily, a retrospective cohort study in Hong Kong has shown.

Empagliflozin 25 mg confers greater kidney protection than SGLT2i 10 mg in T2D

03 Nov 2025

News & Updates

Filter by Specialty:

Specialty:

CGM improves glycaemic excursion detection in T2D patients on haemodialysis

CGM improves glycaemic excursion detection in T2D patients on haemodialysis

For Asians with PCOS, ovarian reserve remains high even at advanced maternal age

For Asians with PCOS, ovarian reserve remains high even at advanced maternal age

Closed-loop insulin system improves T1D management in pregnancy

Closed-loop insulin system improves T1D management in pregnancy

Breastfeeding may help prevent early puberty

Breastfeeding may help prevent early puberty

High plasma triglycerides protect patients with PD against cognitive impairment

High plasma triglycerides protect patients with PD against cognitive impairment

Liraglutide promotes weight loss after suboptimal response to bariatric surgery

Liraglutide promotes weight loss after suboptimal response to bariatric surgery

High BMI tied to ulnar nerve entrapment development in nondiabetic individuals

High BMI tied to ulnar nerve entrapment development in nondiabetic individuals

SGLT-2i lowers autoimmune rheumatic disease risk in T2D

SGLT-2i lowers autoimmune rheumatic disease risk in T2D

Semaglutide safe for dialysis patients in pooled analysis

Semaglutide safe for dialysis patients in pooled analysis

Empagliflozin 25 mg confers greater kidney protection than SGLT2i 10 mg in T2D

Empagliflozin 25 mg confers greater kidney protection than SGLT2i 10 mg in T2D